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Aging is one of the main risk factor for the onset of cardiovascular diseases; one of the possible explanations could be linked to the
age-associated overproduction of free radicals. This increase of oxidative stress can be overcome with a high intake of food
antioxidants. In this context, a number of studies have been addressed to assess the antiaging potential of natural antioxidant
compounds. Recently, it has been shown that the juice of bergamot (Citrus bergamia Risso et Poiteau), a fruit mostly produced
in the Ionian coastal areas of Southern Italy (Calabria), is a valuable source of health-promoting constituents with, among other,
antioxidant properties. In order to investigate the potential antiaging eﬀects of this Mediterranean natural antioxidant source,
bergamot juices of three diﬀerent cultivars (“fantastico,” “femminello,” and “castagnaro”) were herein characterized by the mean
of high-performance liquid chromatography-photodiode array-electrospray ionization-tandem mass spectrometry. Then, juices
were investigated for the evaluation of total polyphenolic and ﬂavonoid contents, cell-free model antioxidant activities, and
in vitro antiaging properties on two diﬀerent cellular models of induced myocardial senescence. The best performing juice was
also assessed in vivo. The phytochemical proﬁles conﬁrmed that juices were rich in ﬂavonoids, both ﬂavone and ﬂavanone
glycosides. In addition, two limonoid glycosides were also identiﬁed in all cultivars. Each cultivar showed diﬀerent phenolic and
ﬂavonoid contents. In tube results showed the juice robust antioxidant activities that correlate with their phenolic and ﬂavonoid
contents. Moreover, for the ﬁrst time, the ability of juice to counteract the chemical-induced senescence was here demonstrated
in both cellular models. Lastly, the in vivo data obtained from mouse hearts evidenced an increase in transcription of genes
involved in antiaging and antioxidant responses. The overall results suggest that bergamot juice exerts antioxidant and
antisenescence eﬀects, making it useful for nutraceutical purposes.
1. Introduction
The pathogenesis of many age-associated diseases can be due
to an increase of oxidative stress; indeed, the overproduction
of free radicals could impair protein and fatty acid functions
and could lead to DNA damage, predisposing to age-related
disorders [1]. In particular, old age is a primary nonmodiﬁ-
able risk factor for the onset of cardiovascular diseases.
DNA damage and telomere shortening are associated with
cellular senescence, atherosclerosis, coronary artery disease,
and heart failure [2]. Furthermore, the accumulation of dys-
functional mitochondria in aged cardiomyocytes could alter
the redox state and contribute to the pathological myocardial
remodeling and heart failure [3].
In this line, a great deal of interest has been recently
devoted to the antiaging potential of natural compounds with
antioxidant properties [4]. Epidemiological studies have evi-
denced that a high intake of antioxidant-containing food is
associated with a reduced risk of cardiovascular diseases. In
particular, the Mediterranean diet (containing antioxidants,
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omega-3 and -6 polyunsaturated acids, polyphenols, ﬂavo-
noids, and procyanidins) is associated with higher longevity
and reduced risk of age-related vascular disease development
[5]. A number of human dietary intervention trials have
shown improvements in vascular function following the con-
sumption of foods with high ﬂavonoid content [6, 7]. Among
these foods, Citrus fruits have gained a high attention for
their content of ﬂavonoids and other beneﬁcial components.
In particular, bergamot (Citrus bergamia Risso et Poiteau), a
fruit mostly produced in the Ionian coastal areas of Southern
Italy (Calabria), has been demonstrated to be a valuable
source of health-promoting molecules that contribute to its
antioxidant, anti-inﬂammatory, and cholesterol reduction
capacities [8–17]. C. bergamia is a small tree; it belongs to
the Rutaceae family, mainly cultivated in a speciﬁc area of
Calabria, characterized by a microclimate suitable for its
growth. Whereas the bergamot essential oil obtained from
the fruit peel is extensively characterized [18–20] and used
in cosmetic and food industries, only recently the bergamot
by-products, such as the pulp and its juice, were evaluated
for their healthy biological properties [8, 11, 21–25]. This
reevaluation could represent an economic advantage in the
industrial processes, reducing costs of their disposal and
gaining a good source of beneﬁcial compounds. Further-
more, the promotion of the bergamot fruit may have impor-
tant economic implications for the regions in which this fruit
can be cultivated.
To the best of our knowledge, no studies investigat-
ing antisenescence property of bergamot juice have been
performed so far. Thus, in order to explore the potential
cardiovascular antiaging eﬀects of this natural antioxi-
dant source, bergamot juices of three diﬀerent cultivars
(“fantastico,” “femminello,” and “castagnaro,” usually
used in the industry) were herein characterized by the means
of high-performance liquid chromatography-photodiode
array-electrospray ionization-tandem mass spectrometry
(HPLC-PDA-ESI-MS/MS). Then, the juices were investi-
gated for the evaluation of total polyphenolic (TPC) and ﬂa-
vonoid (TFC) contents and for the cell-free model
antioxidant activities by superoxide radical scavenging activ-
ity (O2
•−), ferric reducing antioxidant power (FRAP), and
lipid peroxidation inhibition (β-carotene bleaching, BCB)
tests; ﬁnally, the relative antioxidant capacity index (RACI)
was calculated. In vitro antiaging properties were tested on
two diﬀerent cellular models of chemical-induced senescence
of myocardial cell line H9c2 derived from rat hearts. Lastly,
the best performing juice was also assessed in vivo.
2. Materials and Methods
2.1. Chemicals and Apparatus. Solvents such as methanol,
chloroform, phosphoric acid, hydrochloric acid, and glacial
acetic acid were purchased from Carlo Erba (Milano, Italy).
N,N-dimethylformamide (DMF) was obtained from Alfa
Aesar (Karlsruhe, Germany). Acetonitrile HPLC grade were
purchased from VWR (Milano, Italy). HPLC grade water
(18mΩ) was prepared by a Mill-Q puriﬁcation system
(Millipore Corp., Bedford, MA, USA). Dimethyl sulfoxide
(DMSO), doxorubicin (DOX), hydrogen peroxide (H2O2),
p-formaldehyde, Folin-Ciocalteu reagent 2N, sodium car-
bonate, aluminum chloride, sodiumnitrate, sodium nitroprus-
side (SNP), sulfanilamide, N-(1-naphthyl) ethylenediamine
dihydrochloride, phenazine methosulphate (PMS), β-nico-
tinamide adenine dinucleotide (NADH), nitrotetrazolium
blue chloride (NBT), potassium phosphate monobasic
(KH2PO4), sodium acetate trihydrate, 2,4,6-tripyridyl-s-tri-
azine (TPTZ), iron(III) chloride (FeCl3·6H2O), β-carotene,
linoleic acid, Tween 20, sodium hydroxide, gallic acid, quer-
cetin, naringin, ascorbic acid, 6-hydroxy-2,5,7,8-tetramethyl-
chroman-2-carboxylic acid (Trolox), butylhydroxytoluen
(BHT, 2,6-bis (1,1-dimethylethyl)-4-methylphenol), Dulbec-
co’s modiﬁed Eagle’s medium (DMEM), fetal bovine serum
(FBS), penicillin, and streptomycin were purchased from
Sigma-Aldrich (Milano, Italy). CellTiter 96® AQueous Non-
Radioactive Cell Proliferation Assay (MTS) was obtained
from Promega Italia Srl (Milano, Italy).
All spectrophotometric measurements were done in
cuvettes or 96-well microplates on a UV/vis spectrophotom-
eter (SPECTROstar Nano, BMG LABTECH).
2.2. Plant Material. Three diﬀerent cultivars of C. bergamia
(“fantastico,” “femminello,” and “castagnaro”) were supplied
by Young Fruit and Visalli Diego companies (Reggio Cala-
bria, Italy). Fresh fruits of each cultivar were squeezed using
a manual citrus juicer, and the obtained juices were stored
at −20°C and defrosted to room temperature before analyses.
2.3. Sample Preparation. For HPLC-PDA-ESI-MS study,
10.0mL of each juice was added to DMF (10.0mL) and the
mixture was centrifuged three times for 5min at 1145×g.
The supernatant liquid was ﬁltered through a 3mm diameter
PTFE membrane with a 0.45μm pore size. Aliquots of 10μL
were injected into the LC-MS system.
For the evaluation of TPC, TFC, and antioxidant activi-
ties, juices were lyophilized and then dissolved in methanol.
For the assessment of antisenescence activity, lyophilized
juices were dissolved in DMSO. The samples were sonicated
and centrifuged.
2.4. HPLC-PDA-ESI-MS/MS Analyses. Qualitative HPLC-
PDA-ESI-MS/MS analyses were performed using a Surveyor
LC pump, a Surveyor autosampler, coupled with a Surveyor
PDA detector, and a LCQ Advantage ion trap mass spec-
trometer (Thermo Finnigan) equipped with Xcalibur 3.1
software. Analysis was performed using a 4.6× 150mm,
4μm, Synergi Fusion-RP column (Phenomenex). The eluent
was a mixture of acetonitrile (solvent A) and water (solvent
B). The solvent gradient was as follows: 0–15min 5–20%,
15–40min 20–70% A, and 40–45min 70–100% A. Elution
was performed at a ﬂow rate of 0.8mL/min with a splitting
system of 2 : 8 to the MS detector (160μL/min) and PDA
detector (640μL/min), respectively. The volume of the
injected juice DMF solutions was 10μL. Analyses were per-
formed with an ESI interface in the negative mode. The
ionization conditions were optimized, and the parameters
used were as follows: capillary temperature, 210°C; capillary
voltage, −10.0V; tube lens oﬀset, −50.0V; sheath gas ﬂow
rate, 60.00 arbitrary units; auxiliary gas ﬂow rate, 20.00
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arbitrary units; spray voltage, 4.50 kV; and scan range of m/z
150–1200. In the MS/MS experiments, normalized collision
energy 35.0% was applied. N2 was used as the sheath and
auxiliary gas. PDA data were recorded with 200–600nm
range with two preferential channels as the detection wave-
length 280 and 325 nm. In order to determine the amount
of main bergamot juice ﬂavonoids, calibration curve was
constructed by using the naringin as external standard in a
concentration range 0.0020–0.25mg/mL and DMF as sol-
vent. Six diﬀerent concentrations of standard solutions
(0.250, 0.125, 0.060, 0.030, 0.0075, and 0.002mg/mL) were
prepared and analysed by triplicate injections. The calibra-
tion curve was generated by using concentration (mg/mL)
with respect to the area obtained from the integration of
the PDA/UV peaks recorded at 325nm. The relation between
variables was analyzed using linear simple correlation. For
the linear regression of the standard, R2 was 0.9997. The ﬂa-
vonoid amounts were obtained by using a GraphPad Soft-
ware Prism 6.0 and ﬁnally expressed as mg/mL of fresh juice.
2.5. Total Polyphenol Content. Folin-Ciocalteu assay was
used to determine the total polyphenol content of samples
[26]. Distilled water (425μL) and 75μL of the diluted sample
(methanol in blank) were added to 500μL of Folin-Ciocalteu
reagent and 500μL of Na2CO3 (10% w/v). The mixture was
mixed and incubated for 1 h in the dark at room temperature.
The absorbance was measured at 723 nm after incubation.
Gallic acid was used as standard, and results were expressed
as mg gallic acid equivalents per gram of the dried sample
(mgGAE/g) from three independent assays.
2.6. Total Flavonoid Content. One hundred μL of each sam-
ple (methanol in blank) was added to 15μL of 5% NaNO3
into the microcentrifuge tube. After 5min, 30μL of 10%
AlCl3 was added; after some minutes, 100μL of 1M NaOH
solution and 255μL of distilled water were added. The
absorbance was measured against blank at 510nm after
10min of incubation at room temperature. Quercetin was
used as standard, and the total ﬂavonoid content was
expressed as mg of quercetin equivalents per gram of the
dried sample (mgQE/g) from three independent assays [27].
2.7. In Tube Activity
2.7.1. Superoxide Radical (O2
•−) Scavenging Activity. Super-
oxide radicals (O2
•−) were generated in the PMS/NADH sys-
tem, as previously reported [28]. The reaction mixture
consisted of 40μL of diﬀerent concentrations of the sample
(methanol in negative control), 40μL of NADH, and
130μL of NBT. The reaction was started by adding of PMS
(40μL) to the mixture. The superoxide scavenging capacity
of methanol samples was quantiﬁed by their ability to inhibit
NBT reduction to blue formazan by superoxide. The assay
was conducted at room temperature, and the absorbance of
formazan produced was determined at 560 nm for 2min in
kinetic function. Results were expressed in mg/mL as con-
centration of the sample required to inhibit the activity by
50% (IC50) from three independent assays. Ascorbic acid
was used as positive control.
2.7.2. Ferric Reducing Antioxidant Power. The ferric reducing
antioxidant power of samples was determined using FRAP
assay with some modiﬁcations [29]. Brieﬂy, 25μL of appro-
priately diluted sample (methanol in blank) was added to
225μL of FRAP reagent and incubated at 37°C for 40min
in the dark. FRAP reagent was prepared fresh before experi-
ment by mixing 300mM acetate buﬀer in distilled water
pH3.6, 20mM FeCl3·6H2O in distilled water, and 10mM
TPTZ in 40mM HCl in a proportion of 10 : 1 : 1. The reduc-
tion of a colorless ferric complex (Fe3+-tripyridyltriazine) to a
blue-colored ferrous complex (Fe2+-tripyridyltriazine) by
action of electron-donating antioxidants was determined at
593 nm. Trolox was used as standard, and FRAP values were
expressed as mg of Trolox equivalents per gram of the dried
sample (mg TE/g) from three independent assays.
2.7.3. Lipid Peroxidation Inhibition Assay. The ability of sam-
ples to prevent the inhibition of lipid peroxidation was car-
ried out by BCB assay as reported by Dekdouk et al. [26]. A
stock solution of β-carotene/linoleic acid was made by dis-
solving 0.2mg of β-carotene in 0.2mL of chloroform, lino-
leic acid (20mg), and Tween 20 (200mg). The chloroform
was completely removed by a rotary evaporator, and dis-
tilled water (50mL) was added with oxygen. The resulting
emulsion was vigorously stirred. Aliquots (950μL) of the
mixture were transferred to test tubes containing 50μL of
the sample (the ﬁnal concentration for all tested samples
was 0.25mg/mL) or methanol as blank. BHT was used as
a positive standard. 250μL of this solution was transferred
to a 96-well plate, and outer wells were ﬁlled with 250μL of
water to provide a large thermal mass because the reaction
was temperature-sensitive. The microplate was immediately
placed at 50°C for 180min, and the absorbance was moni-
tored at 470nm every 30min. Results, from three indepen-
dent assays, were expressed as percentage of antioxidant
activity (% AA) measured on the basis of BCB inhibition
and calculated as follows:
%AA = 1 −
Abs sampleT0′ −Abs sampleT180′
Abs blankT0′ −Abs blankT180′
∗ 100 1
2.7.4. RACI Calculation. To get a complete and dynamic
picture of the ranking of food antioxidant capacity, the
relative antioxidant capacity index was calculated. Previous
data conﬁrmed that RACI is a valid tool to assess food anti-
oxidant capacity [30]. RACI was calculated by integrating
the antioxidant capacity values generated from the diﬀerent
cell-free model methods.
2.8. In Vitro Activity
2.8.1. Cell Culture. H9c2 cells (normal primary cardiomyo-
cytes; ATTC, Manassas, VA, USA) were cultured, following
the usual procedures, in DMEM supplemented with 10%
FBS, 100 units/mL penicillin, and 100mg/mL streptomycin
in tissue culture ﬂasks at 37°C in a humidiﬁed atmosphere
of 5% CO2.
2.8.2. Cell Viability. H9c2 cells were seeded at a density of
10× 103 cells/cm2 in 96-well plates. “Fantastico” bergamot
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juice was dissolved in DMSO at a concentration of
100mg/mL (stock preparation). After 24 h, the cells were
treated for three days with fresh growth medium containing
the lyophilized “fantastico” bergamot juice dissolved in
DMSO, ranging from 0.01 to 1mg/mL (DMSO 0.01%), or
vehicle. Cell viability was then determined using the MTS
assay according to manufacturer’s instruction. The absor-
bance of formazan at 490nm was measured in a colorimetric
assay with an automated plate reader from three independent
assays (Victor Wallac 2, Perkin Elmer).
2.8.3. Senescence-Associated β-Galactosidase Staining. Cell
senescence in H9c2 cells was induced by DOX or H2O2, as
previously reported [31, 32]. Brieﬂy, cells were cultured up
to about 80% conﬂuence in DMEM medium; before the
experiments, cells were seeded onto 24-well plates at a den-
sity of 10× 103 cells/cm2. After time to allow the cell attach-
ment (24 h), the medium was replaced in each well and the
cells received diﬀerent treatments for 3 h, H2O2 (ranging
from 5 to 100μM), DOX (0.01, 0.05, and 0.1μM), or relative
vehicles. Subsequently, the cells were cultured for 3 days,
after which senescence was determined.
To evaluate the number of senescent cells after 3 days
from DOX or H2O2 insults, the senescence marker sa-β-Gal
was detected as previously reported [33]. In parallel experi-
ments, diﬀerent concentrations of lyophilized “fantastico”
bergamot juice dissolved in DMSO (0.01, 0.1 and 1mg/mL)
or vehicle (0.01% DMSO) were added to the cell medium
after the DOX or H2O2 senescence insults and maintained
in the medium for three days before assessing the sa-β-Gal
staining. According to the literature, treated cells were
ﬁxed in p-formaldehyde and incubated in a dry incubator
in freshly prepared staining solution for 16h at 37°C [34].
Cells were then washed in phosphate-buﬀered saline (PBS)
(1x) and photographed at 100x magniﬁcation. Images of
random light microscopic ﬁelds were captured (5 ﬁelds per
well), and both blue and total cells were counted using Ima-
geJ (ImageJ Software, version 1.41, USA). Three independent
assays were performed.
2.9. In Vivo Activity
2.9.1. Chronic Treatment. C57BL/6J mice were taken from
Envigo (Milan, Italy). All procedures were performed
according to European (EEC Directive 2010/63) and Italian
(D.L. 4 March 2014 n. 26) legislation. Animals were housed
in cages with free access to standard food pellets and water
on a 12 h light/dark cycle.
Nine-month-old male mice (25–30 g) were randomly
assigned into two groups: one group was used as a control
while the other group received lyophilized “fantastico” ber-
gamot juice diluted in water (1mg/kg/day). The ﬁnal con-
centration of the lyophilized juice was 1mg/mL, and the
diluted solution was daily prepared. Mice were weekly
weighed, and water intake was daily monitored over a
period of three months. At the end of treatment, mice were
fasted overnight to measure blood glucose levels. Blood was
collected from the tail tip, and glucose concentration was
determined using the Glucocard™ blood glucose meter
(Menarini). Then, mice were anaesthetized with an intraper-
itoneal injection of aqueous urethane solution 30% w/w
(Sigma-Aldrich). Intracardiac blood was collected in tubes
with the anticoagulant EDTA (BD Vacutainer), in order to
measure the complete lipid panel (tryglicerides, total choles-
terol, HDL, and LDL) and glycated haemoglobin (using
cobas b 101 instrument, Roche Diagnostics). Finally, hearts
were taken, and an amount was immediately processed to
extract the total RNA, in order to assess three genes relevant
to aging, lifespan, and antioxidant response (SIRT1, NRF2,
FOXO3, HO-1, and NQO1).
2.9.2. RNA Extraction and Real-Time PCR Analysis. Total
RNA from mouse hearts was extracted using the RNeasy®
Mini Kit (Qiagen, Hilden, Germany) according to the manu-
facturer’s instructions. Purity of the RNA samples was
determined by measuring the absorbance at 260 : 280 nm.
cDNA synthesis was performed with 500ng of RNA using
the i-Script cDNA synthesis kit (Bio-Rad, Hercules, USA)
following the manufacturer’s instructions. Primers used for
RT-PCR were designed in intron/exon boundaries to ensure
that products did not include genomic DNA (Table 1)
[35–37]. RT-PCR reactions consisted of 25μL Fluocycle® II
SYBR® (EuroClone, Milan, Italy), 1.5μL of both 10μM for-
ward and reverse primers for SIRT1, NRF2, FOXO3, HO-1,
NQO1, and GAPDH (Sigma-Aldrich, Milan, Italy), 3μL
cDNA, and 19μL of H2O. All reactions were performed for
38 cycles using the following temperature proﬁles: 94°C for
30 s (initial denaturation); Annealing temperature °C (see
Table 1) for 30 s (annealing); and 72°C for 1 s (extension).
GAPDH was used as the housekeeping gene. mRNA levels
for each sample were normalized against GAPDH mRNA
levels, and relative expression was calculated by using the
Ct value. PCR speciﬁcity was determined by both the melt-
ing curve analysis and gel electrophoresis.
2.10. Statistical Analyses. The nonlinear multipurpose curve-
ﬁtting program GraphPad Prism (GraphPad Software Inc.,
San Diego, CA) was used for data analysis and graphic pre-
sentations. The cell-free model antioxidant activity data were
expressed as mean± standard deviation of three independent
experiments. Pearson coeﬃcient was used to determine the
correlation among polyphenol and ﬂavonoid contents and
antioxidant activity. The in vitro antisenescence activity
data are presented as the means± standard errors of the
means (SEM) of triplicate samples and are representative
of three diﬀerent experiments. Statistical analysis was per-
formed by one-way analysis of variance (ANOVA) with
Bonferroni’s corrected t-test for post hoc pair-wise compari-
sons. p < 0 05 was considered statistically signiﬁcant.
3. Results and Discussion
3.1. Juice Composition. In the present study, the HPLC-
PDA proﬁles recorded at 325nm of the three C. bergamia
juices obtained from the diﬀerent cultivars are displayed
in Figure 1.
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Compounds 1–14 were detected in all cultivars and were
identiﬁed comparing their HPLC elution orders, ESI-MS/
MS, and UV data (Table 2) with those previously reported.
In agreement with previous studies, our investigation
about the chemical composition of bergamot juices led to
identiﬁcation of citric acid (1) [38], the ﬂavonoids vicenin-2
(2), lucenin-2 4′-methyl ether (3), neoeriocitrin (4), naringin
(8), neohesperidin (9), 3-hydroxy-3-methylglutaryl-neoerio-
citrin (10), neodiosmin/chrysoeriol 7-O-neohesperidoside
(11), melitidin (12), and brutieridin (13) [39, 40]. The ESI-
MS/MS technique has been useful for the identiﬁcation of
components that can occur as isomers in the Citrus juice.
In particular, compound 4 was distinguished by its isomer
eriocitrin due to its fragmentation pattern in which the base
peak is represented by product ion at m/z 459 instead of m/z
287, as observed in the MS/MS experiment of eriocitrin [39].
Similarly, the base peak generated by MS/MS analysis of
compound 8 was observed at m/z 459, in agreement with
the fragmentation pathway of naringin [39], whereas the iso-
mer narirutin is characterized by a most abundant product
ion at m/z 287 [41]. The obtained data conﬁrmed the berga-
mot juice composition, well established in many previous
studies demonstrating that it is rich in ﬂavonoid constitu-
ents, including both ﬂavone and ﬂavanone glycosides [39].
In addition, herein, the two limonoids, limonin glucoside
(5) and nomilinic acid glucoside (14), were also identiﬁed.
Limonoids are a class of bitter components of bergamot fruits
and are generally abundant in Citrus seeds, but they are also
present in pulps, peels, and juices, as reported in a recent
work [40].
Lastly, the peak at retention time (tR) 21.62min was
generated by the coelution of two compounds (6 and 7)
that have not been previously detected in C. bergamia.
Compounds 6 and 7 remained not identiﬁed, but we tenta-
tively hypothesized their structures basing on full MS and
MS/MS spectra (Figure 2).
Full spectrum of compound 6 displayed a deproto-
nated molecule [M−H]− at m/z 901. The MS/MS product
ion spectrum showed ions at m/z 757 generated by the loss
of a 3-hydroxy-3-methylglutaryl moiety ([M−H−144]−) and
595, resulting from the loss of a 3-hydroxy-3-methylglutaryl
residue followed by one hexose molecule ([M−H−144
−162]−). The base peak ion at m/z 595 can be attributed to
eriocitrin or neoeriocitrin, two ﬂavanone O-glycoside isomers
previously reported in C. bergamia juice [39]. A very similar
fragmentation proﬁle was shown by MS/MS of compo-
nent 7, obtained at m/z 855, producing ions at m/z 741
([M−H−144]−) and 579 ([M−H−144−162]−), leading to
suppose that compound 7 can be a naringin or narirutin
([M−H]− at m/z 579) with a hydroxy-3-methylglutaryl moi-
ety and a hexose residue linked to the molecule.
The quantiﬁcation of the main ﬂavonoids detected in all
sample juices was determined on the naringin basis by
HPLC-PDA recorded at 325nm. Results obtained from
quantitative analysis are listed in Table 3.
3.2. Total Polyphenol and Flavonoid Content. TPC and
TFC of juices obtained from “fantastico,” “femminello,”
and “castagnaro” cultivars of C. bergamia fruits were then
investigated. Each cultivar showed diﬀerent phenolic and
ﬂavonoid contents (Table 4).
In particular, TPC ranged from 8.77± 0.77 to 17.10±
1.34mgGAE/g of the sample in “castagnaro” and “fantas-
tico,” respectively. TFC, instead, varied from 6.51± 0.61 to
57.46± 3.20mgQE/g of the sample again in “castagnaro”
and “fantastico,” respectively. The values of TPC are in
accordance with Sicari and Pellicanò [42], although in that
case, fresh juice has been used as the sample, whereas here
juices have been previously lyophilized.
3.3. In Tube Antioxidant Activity. In order to characterize the
total antioxidant capacity of bergamot juices [27], four diﬀer-
ent and complementary assays were herein used to evaluate
juice antioxidant activities. The samples were evaluated
ﬁrstly for their antiradical activity against superoxide and
nitric oxide physiological radicals. Then, samples were
Table 1: Nucleotide sequences, annealing temperature, and product size of the primers utilized in real-time RT-PCR experiments.
Primer nucleotide sequences Annealing temp (°C) Product size (base pairs)
SIRT1
For. 5 ATGACGCTGTGGCAGATTGTT 66.8
202
Rev. 5′ CCGCAAGGCGAGCATAGAT 67.4
NRF2
For. 5′ GGACATGGAGCAAGTTTGGC 66.8
165
Rev. 5′ TCCAGCGAGGAGATCGATGA 68.4
FOXO3
For. 5′ AGTGGATGGTGCGCTGTGT 67.1
100
Rev. 5′ CTGTGCAGGGACAGGTTGT 64.0
HO-1
For. 5′ ATACCCGCTACCTGGGTGAC 64.9
200
Rev. 5′ TGTCACCCTGTGCTTTGACCT 67.0
NQO1
For. 5′ TTCTGTGGCTTCCAGGTCTT 63.8
130
Rev. 5′ AGGCTGCTTGGAGCAAAATA 63.7
GAPDH
For. 5′ ATGTGTCCGTCGTGGATCTGAC 68.5
132
Rev. 5′ AGACAACCTGGTCCTCAGTGTAG 63.4
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assessed for their abilities to reduce ferric ions and to inhibit
the lipid peroxidation (Table 4). Two of the used tests (O2
•−
and FRAP) have not been previously reported for measuring
the activity of bergamot juice samples. Last, the RACI was
also calculated.
3.3.1. O2
•− Scavenging Activity. O2
•− is a radical oxygen spe-
cies normally produced inside the body, but it is known to
be very harmful to cellular components as a precursor of
a more reactive oxygen species, for example, the hydroxyl
radical. The activity of ascorbic acid (IC50 = 4.34± 0.39mg/
mL), used as reference, was compared with the samples by
IC50 values (Table 4). Juice obtained from “castagnaro”
exhibited the lowest IC50 value (IC50 = 1.01± 0.02mg/mL),
followed by “fantastico” (IC50 = 1.13± 0.11mg/mL). Both
these juices demonstrated to have a stronger superoxide
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Figure 1: HPLC-PDA proﬁles of C. bergamia juices from “fantastico” (a), “femminello” (b), and “castagnaro” (c) cultivars. Peaks were
monitored at 325 nm. For the peak data, see Table 2.
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radical scavenging activity than ascorbic acid. Juice obtained
from “femminello” exhibited an activity (IC50 = 4.77± 0.58)
similar to ascorbic acid. The scavenging activities were in
accordance with previous investigation [10].
3.3.2. Ferric Reducing Antioxidant Power. FRAP test eval-
uates the ability of plant extracts to reduce ferric ions. In
our study, the FRAP assay revealed that “fantastico” cultivar
had the highest reducing power (9.83± 0.54mgTE/g),
followed by “femminello” and “castagnaro” (8.43± 0.67 and
6.85± 0.63mgTE/g, respectively) (Table 4).
3.3.3. Lipid Peroxidation Inhibition Test. To get a wider
overview of the antioxidant potential, the antioxidant
eﬀect of the samples on the peroxidation of linoleic acid
in the β-carotene/linoleic acid system was also investi-
gated by a BCB test. The oxidation of linoleic acid gen-
erates peroxyl free radicals, which will then oxidize the
highly unsaturated β-carotene. The presence of antioxi-
dants minimizes the oxidation of β-carotene. All samples
showed moderate β-carotene bleaching inhibition activity; in
fact, results ranged from 22.42± 1.15 to 31.60± 0.50 %
and the highest value was found in cultivar “castagnaro”
(Table 4).
3.3.4. Relative Antioxidant Capacity Index. Moreover, RACI
was calculated among all the tested samples. All methods
used for antioxidant activity determination together with
TPC were included in RACI calculation. In particular, TPC
assay results were included since it was recently proposed
that the results obtained by the Folin-Ciocalteu procedure
could be also interpreted as an alternative way to measure
the total reducing capacity of samples as the reagent reacts
with any reducing substance [26]. Results of antioxidant
activity expressed as IC50 were converted in 1/IC50 before
the RACI calculation, and data of relative antioxidant activity
were represented as histograms (Figure 3).
According to the obtained results, “fantastico” cultivar
had the highest RACI (0.55), followed by “castagnaro”
(−0.09), and “femminello” (−0.45).
Recently, Sicari and Pellicanò [42] have investigated C.
bergamia cultivar juices using two radical scavenging assays
(2,2′-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid, ABTS,
and 1,1-diphenyl-2-picrylhydrazyl, DPPH). The highest
antioxidant capacity has been found in “castagnaro” juice
compared to “fantastico” and then “femminello”. On the
contrary, comparing the radical scavenging activity of the
three bergamot cultivars using just DPPH assay, the previous
paper [39] has established “femminello” more active than
“fantastico” and “castagnaro” cultivars.
These discrepancies among literature and in respect to
present results may be ascribed to the fruit phenolic content
that depends on many factors, such as the degree of maturity
at harvest, genetic diﬀerences, and environmental conditions
[42]. Notably, statistically signiﬁcant diﬀerences on antioxi-
dant activity and phenolic composition of bergamot fruits
collected in diﬀerent Calabria areas have been evidenced,
suggesting that also the microclimate may inﬂuence the
chemical composition and, therefore, the quality of the juice
itself [11].
Table 2: Spectral (UV and ESI-MS/MS), chromatographic data of compounds 1–14, detected in C. bergamia juices from “fantastico,”
“femminello,” and “castagnaro” cultivars.a
Peak Compound tR (min) [M−H]
− MS/MS base peak MS/MS ions (m/z) λmax (nm)
Organic acids
1 Citric acid 2.74 191 111 129, 173, 87 210
Flavone C-glucoside
2 Vicenin-2 16.22 593 473 575, 503, 383, 353 270, 335
3 Lucenin-2 4′-methyl ether 17.57 623 503 605, 533, 503, 413, 383 255, 270, 345
Flavanone O-glycosides
4 Neoeriocitrin 19.98 595 459 441, 287, 235, 205 285
8 Naringin 22.06 579 459 417, 313, 271 280, 330
9 Neohesperidin 22.97 609 301 489, 447 285, 330
Flavone O-glycosides
10 3-Hydroxy-3-methylglutaryl-neoeriotricin 23.19 739 595 637, 677, 459 285, 325
11 Neodiosmin/chrysoeriol 7-O-neohesperidoside 23.57 607 250, 280, 330
3-Hydroxymethylglutaryl ﬂavanone O-glycosides
6 Unidentiﬁed 21.62 901 757 839, 799, 677, 637, 595 270, 345
7 Unidentiﬁed 21.62 885 579 741, 661, 621 265, 345
12 Melitidin 24.47 723 579 661, 621, 579 285, 325
13 Brutieridin 24.92 753 609 691, 651, 301 285, 325
Limonoid glucosides
5 Limonin glucoside 21.41 649 605 461, 443 210
14 Nomilinic acid glucoside 25.40 711 607 651 210
aCompound numbers correspond with peak numbers in Figure 1.
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Figure 2: ESI-MS/MS spectra of compounds 6 and 7. ESI-MS/MS spectra of compound 6 at m/z 901 (a) and compound 7 at m/z 885 (b),
performed in the negative ion mode. For the peak data, see Table 1.
Table 3: Quantitative amount (mg/L of fresh bergamot juice) of the main ﬂavonoids detected in C. bergamia juices from “fantastico,”
“femminello,” and “castagnaro” cultivars by HPLC-PDA analysis at 325 nm.a
Peaks Compounds
Cultivars
“Fantastico” “Femminello” “Castagnaro”
2 Vicenin-2 187.4 78.3 63.0
3 Lucenin-2 4′-methyl ether 140.8 74.4 43.8
4 Neoeriocitrin 103.7 78.3 29.3
8 Naringin 112.8 51.2 42.6
9 Neohesperidin 157.2 91.4 58.0
12 Melitidin 11.2 16.1 16.0
13 Brutieridin 94.1 66.1 27.4
aCompound numbers correspond with peak numbers in Figure 1.
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Then, in order to verify if there was a correlation between
juice amount of polyphenols and antioxidant properties,
Pearson analyses were conducted using averaged values of
each variable, as reported in Table 5.
The highest positive correlation was observed between
FRAP and TPC and TFC (r = 0 89), suggesting a consistent
relationship between polyphenolic and ﬂavonoid content
and the ferric reducing antioxidant power.
On the other hand, it was not noticed a high value of
correlation when O2
•− and BCB were evaluated in compari-
son to phenolic and ﬂavonoids content. This result could be
possibly explained because these tests involved not only phe-
nolic compounds [27]. Moreover, the BCB test mostly gives
an indication of lipophilic active constituents, whereas TPC
assay reports the levels of both lipophilic and hydrophilic
phenols. These data could suggest the presence of minor lipo-
philic and/or not phenolic compounds acting synergistically
to enhance the biological activity.
3.4. Antisenescence Activity
3.4.1. H9c2 Mitochondrial Metabolic Activity. Although from
embryonal origin, H9c2 cells were found to be closer for
energy metabolism features to normal primary cardiomyo-
cytes, H9c2 cells have been successfully used as an in vitro
model to simulate cardiac ischemia-reperfusion injury [43].
Moreover, this cell line is widely used as a successful cellular
model for studies of myocardial pathophysiology including
aging processes [31, 32].
As a ﬁrst step, in order to assess if bergamot juice aﬀected
per se cellular life/death processes, the mitochondrial met-
abolic activity was explored in H9c2 cells by the use of a
tetrazolium dye. The mitochondrial metabolic activity is
a parameter conventionally used to estimate cellular prolifer-
ation and drug toxicity. Cells were treated with the lyophi-
lized bergamot juice of “fantastico” cultivar, which showed
the highest antioxidant potential and represent about 90%
among the three cultivars. The results demonstrated that
bergamot juice did not exert any cytotoxic eﬀect on H9c2
cells (Figure 4). Indeed, no diﬀerence was observed in the
mitochondrial metabolic activity following three days of
treatment in samples compared to control.
3.4.2. H9c2 Cell Senescence Induction. H9c2 cell senescence
was induced by cell exposure to exogenous oxidative insults
(doxorubicin, DOX, or hydrogen peroxide, H2O2), as
Table 4: Results of O2
•−, FRAP, and BCB tests, beside TPC and TFC, of juices of C. bergamia fruits obtained from cultivars “fantastico,”
“femminello,” and “castagnaro”. mgGAE/g =mg of gallic acid equivalents per gram of the dried sample; mgQE/g =mg of quercetin
equivalents per gram of the dried sample; IC50 = concentration of the sample required to inhibit the activity by 50% in mg/mL; mgTE/
g =mg of Trolox equivalents per gram of the dried sample; % AA=percentage of antioxidant activity at ﬁnal concentration of 0.25mg/mL.
Cultivars TPC (mg GAE/g) TFC (mg QE/g) O2
•− (IC50 mg/mL) FRAP (mg TE/g) BCB (% AA)
“Fantastico” 17.10± 1.34 57.46± 3.20 1.13± 0.11 9.83± 0.54 26.18± 0.85
“Femminello” 14.00± 0.56 16.89± 1.50 4.77± 0.58 8.43± 0.67 22.42± 1.15
“Castagnaro” 8.77± 0.77 6.51± 0.61 1.01± 0.02 6.85± 0.63 31.60± 0.50
Ascorbic acid — — 4.34± 0.39 — —
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0.40
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Figure 3: RACI values obtained for the C. bergamia cultivars.
RACI values were obtained comparing the total phenolic content,
the superoxide radical scavenging activity, the ferric reducing
antioxidant power, and the lipid peroxidation inhibition results of
investigated cultivars.
Table 5: Pearson coeﬃcient calculated among TPC, TFC,
superoxide radical scavenging activity, ferric reducing antioxidant
power, and lipid peroxidation inhibition.a
TPC TFC
O2
•− −0.27 0.20
FRAP 0.99 0.93
BCB −0.70 −0.29
aIn bold face the highest positive correlations.
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Figure 4: Eﬀects of C. bergamia “fantastico” cultivar juice on the
mitochondrial oxidative metabolism activity. H9c2 cells were
treated with three diﬀerent concentrations of lyophilized juice,
dissolved in DMSO, and the mitochondrial oxidative metabolism
activity was examined.
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previously reported [31, 32, 34]. The presence of senescence-
associated β-galactosidase (sa-β-Gal) was monitored as a
marker of cellular senescence. For chemical insults, in order
to establish the eﬀective dose of DOX or H2O2 able to induce
cellular senescence, H9c2 cells were challenged with increas-
ing concentrations of DOX (ranging from 0.01 to 0.1μM)
or H2O2 (ranging from 5 to 100μM), diluted in water, for
3 h. Subsequently, the cells were cultured with fresh com-
plete medium for 3 days, and then the presence of sa-β-
Gal was examined. A concentration-dependent increase of
sa-β-gal was observed following the H9c2 cell treatment
with DOX (0.05μM, p < 0 01 and 0.1μM, p < 0 001). Con-
versely, only 60μM H2O2 was eﬀective to induce the stain-
ing of sa-β-Gal signiﬁcantly (p < 0 01). A higher dose of
H2O2 (100μM) did not further increase the senescence
marker, probably due to the cytotoxic eﬀect exerted by such
a high concentration of H2O2. Together, these results
allowed us to establish 0.05μM DOX and 60μM H2O2 as
the eﬀective drug concentrations to be used for the follow-
ing H9c2 cell experiments.
3.4.3. Eﬀects of Bergamot Juice in Cellular Senescence
Models. Therefore, with the aim to explore the protective
potential of bergamot juice against cellular senescence,
the DOX- or H2O2-treated cells were cultured with fresh
complete medium containing diﬀerent concentrations of
“fantastico” bergamot juice (FBJ) and the pivotal senes-
cence hallmark, the sa-β-Gal staining, was assessed after
3 days. Figure 5 showed the results obtained from the
H2O2-induced (light gray bars) and DOX-induced (dark
gray bars) senescence model.
In Figure 5(a), representative phase contrast photomicro-
graphs were reported, in which the sa-β-Gal staining cells are
in light blue. As reported in Figure 5(b), bergamot juice alone
did not aﬀect the number of senescent cells with respect to
control, for any of the tested concentrations. As expected,
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Figure 5: Eﬀects of C. bergamia “fantastico” juice on H9c2 senescence-associated β-galactosidase staining. (a) Representative phase contrast
photomicrographs of control cells, DOX-injured cells, and DOX-injured cells treated with FBJ, 0.1mg/mL. The arrows indicate the blue-
stained cells. (b) Percentage of cellular senescence in not-injured cells treated with diﬀerent concentrations of FBJ. Data are shown as the
percentages of β-galactosidase-positive cells with respect to the total cell number of the sample. Each bar represents the mean± SEM of
three replicates from three independent experiments. (c) Percentage of cellular senescence in H2O2- or DOX-injured cells treated with FBJ
at diﬀerent concentrations. Data are shown as the percentages of β-galactosidase-positive cells with respect to the total cell number of the
sample. Each bar represents the mean± SEM of three replicates from three independent experiments. The light gray bars represent the
data obtained from the H2O2-induced senescence model; the dark gray bars represent the data obtained from the DOX-induced
senescence model. ∗∗∗p < 0 001 versus the control (cells not injured); °°°p < 0 001 versus the H2O2- or DOX-challenged cells with DMSO;°°p < 0 01 versus the H2O2- or DOX-challenged cells with DMSO; °p < 0 05 versus the H2O2- or DOX-challenged cells with DMSO.
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H9c2 cells injured with H2O2 or DOX evidenced a signiﬁ-
cant sa-β-Gal staining in respect of control cells (p <
0 001, ∗ versus control cells; Figure 5(c)), and notably, all
the tested “fantastico” bergamot juice cotreatments were
able to protect the injured cells from the appearing of the
senescence hallmark (p < 0 05 and p < 0 01, ° versus H2O2
or DOX-treated cells; Figure 5(c)). Interestingly, in both
cellular models, the relation between senescence percentages
and FBJ concentrations showed an inversely proportional
trend. These data suggested that the optimal FBJ concen-
tration capable of better counteracting the senescence
mechanism is the lowest one (0.01mg/mL).
To the best of our knowledge, there is another study in
the literature concerning the antisenescence potential of ber-
gamot; this study has evidenced antiaging and immune mod-
ulating responses on human photoaged keratinocytes treated
with a highly concentrated extract of bergamot fruit [44]. In
addition, our results are in accordance with previous ﬁnd-
ings suggesting that the bergamot juice polyphenols could
inﬂuence cellular function by acting as activators of
sirtuin-1 [9], a nuclear histone deacetylase, largely involved
in aging processes [45].
3.4.4. Eﬀects of Bergamot Juice In Vivo. In light of the
antisenescence results, “fantastico” juice eﬀects were also
assessed in old mice. During daily water intake of berga-
mot fruit juice, no diﬀerence between the “bergamot
group” and the “vehicle group” was highlighted along
the three months of treatment. Weekly weightings showed
a physiological increase in the body mass, according to
growth curves reported in the literature (data not shown).
Blood total cholesterol, HDL, LDL, triglyceride, glycaemia,
and glycated haemoglobin values were superimposable
with the corresponding values measured in young-adult
animals, suggesting that these animals did not have car-
diometabolic diseases. Indeed, lipid and glycemic parameters
measured in BFJ and control groups were not signiﬁcantly
diﬀerent (Table 6).
Nevertheless, the real-time PCR analyses, performed on
hearts of the old mice fed with FBJ or vehicle for three
months, showed statistically signiﬁcant increases in mRNA
levels of three regulator genes, SIRT1, NRF2, and FOXO3,
which are largely involved in antiaging and antioxidant
responses (Figure 6).
The silent information regulator 2 family proteins
(SIRT), also called “sirtuins,” have been demonstrated to
coordinate metabolic responses to changes in nutritional
availability and maintain physiological homeostasis. Brain-
speciﬁc Sirt1-overexpressing (BRASTO) transgenic mice
have shown signiﬁcant life span extension and delay in the
aging process compared to control mice [46]. The nuclear
factor erythroid 2-related factor 2 (NRF2) is a regulator of
cellular resistance to oxidants; it orchestrates the expression
of antioxidant response element-dependent genes to regulate
the outcomes of oxidant exposure [47]. Last, forkhead/
winged helix box gene, group O (FOXO) proteins are a
set of transcription factors at a central integration hub
for many important cellular pathways, relevant to healthy
aging and longevity. FOXOs are involved in energy metab-
olism, oxidative stress, proteostasis, apoptosis, cell cycle
regulation, metabolic processes, immunity, inﬂammation,
and stem cell maintenance [48]. Notably, a BFJ-enriched diet
was able to increase the mRNA expression of these three key
genes in mice hearts, suggesting an enhanced cellular antiox-
idant capacity and an antiaging response for those mice fed
with BFJ.
In order to further demonstrate the involvement of these
pathways in the antioxidant eﬀects of the active compounds
contained in bergamot juice, two additional genes, NAD(P)H
dehydrogenase quinine 1 (NQO1) and heme oxygenase
1 (HO-1), routinely assessed as markers of NRF2 activity,
have been investigated. These two NRF2 target genes are
markers of a robust antioxidant response [49]. As reported
in Figure 7, the real-time PCR analyses, performed on hearts
of the old mice fed with FBJ or vehicle for three months,
showed statistically signiﬁcant increases in mRNA levels of
NQO1 and HO-1, suggesting a robust antioxidant eﬀect for
FBJ (Figure 7).
Then, considering that oxidative stress has been pointed
out as relevant cause of both in heart aging and in the devel-
opment of several cardiac diseases, an approach with BFJ
Table 6: Lipid panel, glycaemia, and glycated haemoglobin levels
(HbA1c) of treated mice.
Vehicle FBJ (1mg/mL)
Total cholesterol (mg/dL) 69.5± 0.5 68± 2.57
HDL (mg/dL) 19± 4 17.8± 1.74
LDL (mg/dL) 38.5± 5.5 37.48± 3.06
Triglycerides (mg/dL) 57± 2 62± 1.9
Glycaemia (mg/dL) 91.5± 10.5 85.4± 9.5
HbA1c (mmol/mol) 29± 3 27.4± 0.87
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Figure 6: FBJ induces gene expression. Real-time PCR analyses
showed a statistically signiﬁcant increase in SIRT1, NRF2, and
FOXO3 mRNA levels in hearts of old mice fed with FBJ for three
months. ∗p < 0 05; ∗∗∗p < 0 005.
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could guarantee an improvement of these targets (SIRT1,
NRF2, FOXO, HO-1, and NQO1) typically altered and at
the basis of cardiac dysfunction and of the consequent tissue
damage [50].
Therefore, all together, these data indicated that the
bergamot juice exerts beneﬁcial health eﬀects counteract-
ing senescence in myocardial H9c2 cells and increases
the antiaging and antioxidant defenses in mouse hearts,
opening new perspectives on the potential pharmaceutical
application of this natural source.
4. Conclusions
Natural polyphenols have gained considerable attention as
potential agents for prevention and treatment of oxidative
stress-related diseases, such as aging and cardiovascular dis-
eases [5, 51], and in particular, the Mediterranean citrus fruit
bergamot has been demonstrated to be a valuable source
of antioxidant molecules. In addition, limonoids occurring
in Citrus genus displayed diﬀerent pharmacological activi-
ties; in particular, a placebo-controlled, double-blind study
demonstrated that limonin glucoside may be useful in the
prevention and/or treatment of diﬀerent chronic inﬂamma-
tory diseases, such as cancer, diabetes, and cardiovascular
diseases [52]. The results of our study conﬁrmed that berga-
mot juices possess a robust antioxidant activity and could be
considered a valuable source of health-promoting constitu-
ents, such as naringin, neoeriocitrin, and neohesperidin, as
previously established [11, 39, 41]. Furthermore, to the best
of our knowledge, we demonstrated for the ﬁrst time the
potential of bergamot juice to counteract also the senescence
processes, in vitro and in vivo.
These ﬁndings supported the nutraceutical properties of
the bergamot fruit, encouraging the use of its pulp as
health-promoting resource.
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